New clinical score for disease activity at diagnosis in Langerhans cell histiocytosis

BACKGROUND: The clinical presentation and course of Langerhans cell histiocytosis (LCH) are variable, ranging from an isolated, spontaneously remitting bone lesion to multisystem disease with risk organ involvement. Treatment of LCH ranges from a wait-and-see attitude to intensive multidrug therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Won-ik, Jeong, You Cheol, Kim, Sun Young, Kim, So Dam, Pribis, John Paul, Kim, Hee-Jin, Koh, Kyung-Nam, Im, Ho-Joon, Lee, Young-Ho, Seo, Jong-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208202/
https://www.ncbi.nlm.nih.gov/pubmed/22065974
http://dx.doi.org/10.5045/kjh.2011.46.3.186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208202/
https://www.ncbi.nlm.nih.gov/pubmed/22065974
http://dx.doi.org/10.5045/kjh.2011.46.3.186

Ejemplares similares